| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 5,077,400 | 5,565,000 | 6,267,300 | 6,075,300 | | Cost of Revenue | 3,217,200 | 3,489,200 | 3,904,100 | 3,850,500 | | | Gross Profit | 1,860,200 | 2,075,800 | 2,363,200 | 2,224,800 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 458,600 | 622,300 | 582,100 | 598,700 | | Non Recurring | 1,200 | 62,000 | (92,100) | 21,400 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 1,400,400 | 1,391,500 | 1,873,200 | 1,604,700 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 92,900 | 11,100 | 6,800 | 190,900 | | Earnings Before Interest And Taxes | 1,493,300 | 1,513,300 | 1,830,500 | 1,845,100 | | Interest Expense | 120,900 | 116,200 | 131,600 | 146,300 | | Income Before Tax | 1,372,400 | 1,397,100 | 1,698,900 | 1,698,800 | | Income Tax Expense | 392,900 | 411,800 | 507,600 | 508,300 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 979,500 | 985,300 | 1,191,300 | 1,190,500 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 979,500 | 985,300 | 1,191,300 | 1,190,500 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $979,500 | $985,300 | $1,191,300 | $1,190,500 |
|
0.45% Nasdaq 
0.20%
Income Statement
